source
- Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapiesThe future of medicine is here. See how specialized logistics are saving lives with next-gen cell and gene therapies.BioPharma Dive · 2mo ago↗ source
- The capacity crunch in biopharma is a location problemCell and gene therapies aren’t limited by ideas—they’re limited by where they’re built. See how “ready-now” locations change the math on scaling.BioPharma Dive · 2mo ago↗ source
- Nivolumab Plus SOC Therapy Shows Encouraging Disease Control in Grade Group 5 Prostate CancerThe regimen produced a 2-year freedom from biochemical recurrence rate of 90.3% in grade group 5 prostate cancer.onclive · 2mo ago